Get started
Award

N00014-20-1-2705

Funded outputs count: 47
Funder award ID: N00014-20-1-2705
OpenAlex ID: G5039041663
CD19 CAR T‐Cell Therapy for Primary Mediastinal Large B‐Cell Lymphoma: A CIBMTR Analysis
2025 · Jordan Gauthier, Kwang W. Ahn, et al. · American Journal of Hematology · 7
PDF
Prediction of KIR3DL1 and human leukocyte antigen binding
2025 · Martin Maiers, Yoram Louzoun, et al. · Journal of Biological Chemistry
PDF
Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
2024 · Santiago Mercadal, Kwang Woo Ahn, et al. · Haematologica · 15
PDF
CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma
2024 · Priyanka A. Pophali, Joshua A. Fein, et al. · Blood Advances · 22
Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation
2024 · Amy P. Webster, Simone Ecker, et al. · Frontiers in Genetics · 3
PDF
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)
2024 · Joshua A. Hill, Michael J. Martens, et al. · medRxiv · 2
PDF
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
2024 · Guru Subramanian Guru Murthy, Tao Zhang, et al. · Biomarker Research · 4
PDF
Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry
2023 · Abu Sayed Chowdhury, Martin Maiers, et al. · Transplantation and Cellular Therapy · 36
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis
2023 · Brandon J. Blue, Ruta Brazauskas, et al. · Transplantation and Cellular Therapy · 11
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
2023 · Joshua A. Hill, Michael J. Martens, et al. · EClinicalMedicine · 25
PDF
Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma
2023 · Naresh Bumma, Binod Dhakal, et al. · Cancer · 12
PDF
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
2023 · Guru Subramanian Guru Murthy, Soyoung Kim, et al. · Haematologica · 35
PDF
Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation
2023 · Pietro Crivello, Esteban Arrieta-Bolaños, et al. · Journal of Clinical Oncology · 47
PDF
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
2023 · Guru Subramanian Guru Murthy, Brent R. Logan, et al. · American Journal of Hematology · 24
PDF
Molecular landscape of immune pressure and escape in aplastic anemia
2022 · Simona Pagliuca, Carmelo Gurnari, et al. · Leukemia · 38
PDF
Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia
2022 · Lih-Wen Mau, Jaime M. Preussler, et al. · Transplantation and Cellular Therapy · 11
Limited Contribution of Donor Characteristics to One-Year Survival After Hematopoietic Stem Cell Transplantation
2022 · Sapir Israeli, Martin Maiers, et al. · Transplantation and Cellular Therapy · 2
A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation
2022 · Esteban Arrieta-Bolaños, Pietro Crivello, et al. · Blood · 36
PDF
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
2022 · Rachel Phelan, Annie Im, et al. · Bone Marrow Transplantation · 15
PDF
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia
2022 · Michele Baccarani, Francesca Bonifazi, et al. · Leukemia · 16
PDF
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
2022 · Matthew Mei, Mehdi Hamadani, et al. · Haematologica · 8
PDF
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
2022 · Hemant S. Murthy, Kwang Woo Ahn, et al. · Transplantation and Cellular Therapy · 23
PDF
A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
2021 · Paul J. Martin, David M. Levine, et al. · Frontiers in Immunology · 11
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide
2021 · Ephraim J. Fuchs, Shannon R. McCurdy, et al. · Blood · 119
PDF
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
2021 · Rachel Phelan, Annie Im, et al. · Transplantation and Cellular Therapy · 17
PDF
Year
Topic